Vanderbilt-Ingram Cancer Center (8867) — Nashville, Tennessee

Vanderbilt-Ingram Cancer Center (8867) is a clinical research site located in Nashville, Tennessee, United States 37212.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingram Cancer Center (8867) has participated in 1 clinical trials.

Therapeutic areas: Oncology, Solid Tumors.

Sponsors: EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingram Cancer Center (8867)?

Vanderbilt-Ingram Cancer Center (8867) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingram Cancer Center (8867) conducted?

Vanderbilt-Ingram Cancer Center (8867) has 1 clinical trials on record. Their work covers Oncology, Solid Tumors.

Is Vanderbilt-Ingram Cancer Center (8867) accredited by Crixeo Health?

Vanderbilt-Ingram Cancer Center (8867) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingram Cancer Center (8867)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.